HART:TSXVGold Hart Copper Corp. Analysis
Data as of 2026-03-17 - not real-time
$30.67
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The NYLI Healthy Hearts ETF is trading at the upper end of its recent range (30.67), exactly at the identified resistance level, while the 20‑day SMA (29.63) sits just below the 50‑day (29.91) and 200‑day (29.96) averages, indicating a modest upward bias that is not yet confirmed by price action. RSI is elevated at 68, suggesting overbought conditions, yet the MACD histogram is positive (0.19) with a bullish signal line crossover, hinting at lingering momentum. Volume trends are weakening, with daily volume at 164 versus a 3‑month average of 547, which raises concerns about the strength of any breakout. Volatility remains elevated at 15% over the past 30 days, and the beta of 0.48 points to lower market sensitivity, offering some cushion in broader market swings. The fund’s PE ratio of 21.6 and dividend yield of 1.62% are modestly attractive, especially in an environment where the Fear & Greed Index signals “Extreme Greed,” potentially inflating demand.
From a valuation perspective, the ETF appears fairly priced given its moderate PE and dividend yield, though the lack of underlying earnings data limits a deep intrinsic assessment. Risk factors include decreasing liquidity, medium‑high geographic exposure to emerging markets, and moderate sector and regulatory considerations tied to the health‑care theme. Overall, the technical setup suggests a near‑term pullback risk, while the longer‑term health‑care exposure and dividend payout provide a foundation for a cautious buy‑and‑hold stance.
From a valuation perspective, the ETF appears fairly priced given its moderate PE and dividend yield, though the lack of underlying earnings data limits a deep intrinsic assessment. Risk factors include decreasing liquidity, medium‑high geographic exposure to emerging markets, and moderate sector and regulatory considerations tied to the health‑care theme. Overall, the technical setup suggests a near‑term pullback risk, while the longer‑term health‑care exposure and dividend payout provide a foundation for a cautious buy‑and‑hold stance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price at resistance with overbought RSI
- Decreasing volume indicating weak buying pressure
- Positive MACD histogram but overall bearish trend direction
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Support level near 28.75 provides a floor
- Moderate PE and dividend yield offer some value
- Beta of 0.48 limits market‑wide volatility exposure
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Health‑care exposure aligns with long‑term demographic trends
- Sustainable dividend yield of 1.62%
- Fair valuation with room for upside as market sentiment normalizes
Key Metrics & Analysis
Financial Health
P/E Ratio21.6
Technical Analysis
TrendBearish
RSI68.0
Support$28.75
Resistance$30.67
MA 20$29.63
MA 50$29.91
MA 200$29.96
MACDBullish
VolumeDecreasing
Fear & Greed Index79.14
Valuation
GradeFair
TypeBlend
Dividend Yield1.62%
Risk Assessment
Beta0.48
Volatility15.21%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.